Avyantra
Avyantra strongly believes in fusing technology and innovation for enabling accessible and affordable healthcare in developing countries. They received in 2020 investment from the UNICEF Cryptocurrency Fund (CryptoFund)
Avyantra strongly believes in fusing technology and innovation for enabling accessible and affordable healthcare in developing countries. They received in 2020 investment from the UNICEF Cryptocurrency Fund (CryptoFund)
a blockchain-powered platform designed to give clinical trial participants better trial experiences, and pharma companies a more unified and transparent clinical trial management system. Their blockchain platform, LifeLedger, aims to secure participant data, while using timestamps on the blockchain to help record trial results in an immutable fashion
a collaboration with the company Softel is being analyzed for the handling of medical records and medical information between different institutions
a blockchain-based startup which sequences your DNA, reward you with tokens and DNA interpretations
a platform designed to take genetic services and data analysis and make it more secure with cryptographic protections using blockchain technology. As more and more people gain access to their genetic data, many are seeking ways to safely store that data, to only share it with approved partners, or in the case of volunteering it for research, to anonymize it. DNAtix hopes to be the platform to help secure and make use of genetic data
The patient blockchain that lets you assemble, own and share your health data
a DNA Data Marketplace bringing DNA data owners together with DNA data buyers. DNA data is bought and sold with DNA Tokens on the blockchain
a project that samples your DNA, turns it into data, and stores it in Bitcoin
a comprehensive solution for the genetic data ecosystem in compliance with strict regulatory environment
an innovative project leveraging crypto to reduce costs of prostheses
a public-private partnership between the EU and the European pharmaceutical industry represented by EFPIA. For the Blockchain Enabled Healthcare program, the IMI is earmarking up to Euro 18m which is expected to last three years
a platform of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need worldwide
a decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs
the first open biomedical information network centred on the connection between organisations and individuals, encouraging hospitals to start making anonymised data available for open research, while prompting citizens to become the ultimate owners and controllers of their health data
a multi-stakeholder digital plaform to facilitate sustainable and people-centered public -private partnerships for global health
a startup using blockchain to accelerate the sharing of data in biomedical research. Currently, biomedical research occurs in silos, and key discoveries are made that researchers don’t share because they want to receive credit for publishing first. By placing discoveries and medical data on the blockchain, Translo hopes to provide a platform for sharing biomedical data in a decentralized, secure, efficient, and permissioned manner